Literature DB >> 19631971

Ovarian cancer cells stimulate uPA gene expression in fibroblastic stromal cells via multiple paracrine and autocrine mechanisms.

Vera Noskova1, Sara Ahmadi2, Eleonor Åsander2, Bertil Casslén2.   

Abstract

OBJECTIVES: Expression of uPA mRNA is massively up-regulated in the stroma of poorly differentiated ovarian tumors. We hypothesized that this expression was induced by paracrine signals from the epithelial tumor cells, and established an in vitro model of ovarian cancer microenvironment to study intercellular cross-talk.
METHODS: ES-2 clear cell carcinoma cells were grown in tissue culture inserts in a double-chamber system with fibroblastic stromal LEP cells embedded in Matrigel. Binding-site directed antibodies were used to neutralize soluble cytokines in ES-2 conditioned medium (CM) before incubation with LEP cells. Real time PCR measured uPA mRNA in LEP cells, as well as mRNA for cytokines in both cell types.
RESULTS: Co-culture with ES-2 cells as well as incubation with ES-2 CM induced uPA mRNA in LEP cells about two-fold. In short time (12 h) incubation of LEP cells with CM, antibodies to EGF and bFGF reduced induction of uPA mRNA, suggesting that these cytokines function as paracrine signals. EGF mRNA and bFGF mRNA were also found in ES-2 cells. At longer incubation (24 h) antibodies to bFGF, HB-EGF, HGF, IGF-1, and IL-1alpha reduced uPA mRNA induction, suggesting an autocrine function for these cytokines in LEP cells. In fact, expression of the same five cytokines was up-regulated in LEP cells exposed to CM.
CONCLUSION: We identified two cytokines as paracrine signals, and five cytokines as autocrine signals in ovarian cancer cell induced up-regulation of uPA mRNA in stromal fibroblastic cells. It is crucial to understand intra-tumoral cross-talk, since it can offer new therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631971     DOI: 10.1016/j.ygyno.2009.06.026

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

1.  3D tumour models: novel in vitro approaches to cancer studies.

Authors:  Agata Nyga; Umber Cheema; Marilena Loizidou
Journal:  J Cell Commun Signal       Date:  2011-04-16       Impact factor: 5.782

2.  Cancer associated fibroblasts: the dark side of the coin.

Authors:  Paolo Cirri; Paola Chiarugi
Journal:  Am J Cancer Res       Date:  2011-03-12       Impact factor: 6.166

3.  ERG oncogene modulates prostaglandin signaling in prostate cancer cells.

Authors:  Ahmed A Mohamed; Shyh-Han Tan; Chen Sun; Syed Shaheduzzaman; Ying Hu; Gyorgy Petrovics; Yongmei Chen; Isabell A Sesterhenn; Hua Li; Taduru Sreenath; David G McLeod; Albert Dobi; Shiv Srivastava
Journal:  Cancer Biol Ther       Date:  2011-02-15       Impact factor: 4.742

Review 4.  Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.

Authors:  Isaiah G Schauer; Anil K Sood; Samuel Mok; Jinsong Liu
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

5.  Synthesis of microgel sensors for spatial and temporal monitoring of protease activity.

Authors:  Della S Shin; Emi Y Tokuda; Jennifer L Leight; Connor E Miksch; Tobin E Brown; Kristi S Anseth
Journal:  ACS Biomater Sci Eng       Date:  2017-03-13

6.  Human S100A9 protein is stabilized by inflammatory stimuli via the formation of proteolytically-resistant homodimers.

Authors:  Matteo Riva; Zhifei He; Eva Källberg; Fredrik Ivars; Tomas Leanderson
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

7.  The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer.

Authors:  Zuzana Kolkova; Vera Casslén; Emir Henic; Sara Ahmadi; Anna Ehinger; Karin Jirström; Bertil Casslén
Journal:  J Ovarian Res       Date:  2012-03-18       Impact factor: 4.234

Review 8.  Hepatic stellate cells: central modulators of hepatic carcinogenesis.

Authors:  Alexandra I Thompson; Kylie P Conroy; Neil C Henderson
Journal:  BMC Gastroenterol       Date:  2015-05-27       Impact factor: 3.067

Review 9.  Pericellular proteolysis in cancer.

Authors:  Lisa Sevenich; Johanna A Joyce
Journal:  Genes Dev       Date:  2014-11-01       Impact factor: 11.361

Review 10.  Fibroblast heterogeneity in the cancer wound.

Authors:  Daniel Öhlund; Ela Elyada; David Tuveson
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.